Early diagnosis of lung cancer: which is the optimal choice?

Abstract

The prognosis of lung cancer patients with different clinical stages is significantly different. The 5-year survival of stage IA groups can exceed 90%, while patients with stage IV can be less than 10%. Therefore, early diagnosis is extremely important for lung cancer patients. This research focused on various diagnosis methods of early lung cancer, including imaging screening, bronchoscopy, and emerging potential liquid biopsies, as well as volatile organic compounds, autoantibodies, aiming to improve the early diagnosis rate and explore feasible and effective early diagnosis strategies.

• Authors: Jing Ning, Tao Ge, Minlin Jiang, Keyi Jia, Lei Wang, Wei Li, Bin Chen, Yu Liu, Hao Wang, Sha Zhao, Yayi He
• Journal: Aging (Aging (Albany NY)) Vol. 13 Issue 4 Pg. 6214-6227 (02 11 2021) ISSN: 1945-4589 [Electronic] United States
• PMID: 33591942 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Autoantibodies

Topics

• Autoantibodies (blood)
• Breath Tests
• Bronchoscopy
• Early Diagnosis
• Humans
• Liquid Biopsy
• Lung Neoplasms (blood, diagnosis)
• Radiography